These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 9543692)
1. Intravenous methylprednisolone pulse therapy in the treatment of Graves' ophthalmopathy. Matejka G; Vergès B; Vaillant G; Petit JM; Brun-Pacaud A; Rudoni S; Brun JM Horm Metab Res; 1998 Feb; 30(2):93-8. PubMed ID: 9543692 [TBL] [Abstract][Full Text] [Related]
2. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids]. Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418 [TBL] [Abstract][Full Text] [Related]
3. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial. Wakelkamp IM; Baldeschi L; Saeed P; Mourits MP; Prummel MF; Wiersinga WM Clin Endocrinol (Oxf); 2005 Sep; 63(3):323-8. PubMed ID: 16117821 [TBL] [Abstract][Full Text] [Related]
4. Serum Th1 and Th2 profile cytokine level changes in patients with Graves' ophthalmopathy treated with corticosteroids. Myśliwiec J; Kretowski A; Topolska J; Siewko K; Jakubczyk D; Szelachowska M; Mikita A; Kinalska I Horm Metab Res; 2001 Dec; 33(12):739-43. PubMed ID: 11753760 [TBL] [Abstract][Full Text] [Related]
5. Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy. Aktaran S; Akarsu E; Erbağci I; Araz M; Okumuş S; Kartal M Int J Clin Pract; 2007 Jan; 61(1):45-51. PubMed ID: 16889639 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids]. Brauer VF; Scholz GH Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657 [TBL] [Abstract][Full Text] [Related]
7. Thyrotropin receptor antibodies detected by the human recombinant TBII assay--a surrogate marker for autoimmune activity in Graves' ophthalmopathy? Myśliwiec J; Kretowski A; Stepień A; Mirończuk K; Kinalska I Med Sci Monit; 2002 Sep; 8(9):MT159-62. PubMed ID: 12218953 [TBL] [Abstract][Full Text] [Related]
8. Methylprednisolone pulse therapy in rapidly progressive glomerulonephritis. de Glas-Vos JW; Krediet RT; Arisz L Neth J Med; 1991 Apr; 38(3-4):96-103. PubMed ID: 1881508 [TBL] [Abstract][Full Text] [Related]
9. Intravenous methylprednisolone pulse therapy for Graves' ophthalmopathy. Hiromatsu Y; Tanaka K; Sato M; Kuroki T; Nonaka K; Kojima K; Nishimura H; Nishida H; Kaise N Endocr J; 1993 Feb; 40(1):63-72. PubMed ID: 7951498 [TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of treatment for thyroid orbitopathy in patients hospitalized at the Endocrinology Department of Pomeranian Medical University]. Kulig G; Kaźmierczyk-Puchalska A; Krzyzanowska-Swiniarska B; Pilarska K Przegl Lek; 2004; 61(8):852-4. PubMed ID: 15789915 [TBL] [Abstract][Full Text] [Related]
11. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy. Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743 [TBL] [Abstract][Full Text] [Related]
12. Effect of high-dose intravenous steroid pulse therapy followed by 3-month oral steroid therapy for Graves' ophthalmopathy. Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y Jpn J Ophthalmol; 2002; 46(5):563-7. PubMed ID: 12457917 [TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of HGF and IL-8 in patients with active Graves' orbitopathy before and after methylprednisolone therapy. Nowak M; Siemińska L; Karpe J; Marek B; Kos-Kudła B; Kajdaniuk D J Endocrinol Invest; 2016 Jan; 39(1):63-72. PubMed ID: 26062519 [TBL] [Abstract][Full Text] [Related]
14. [Therapy with large doses of methylprednisolone in Basedow's ophthalmopathy]. Zbranca E; Mogoş V; Nisfoeanu G; Vulpoi C; Gneazdovschi V; Georgescu D Rev Med Chir Soc Med Nat Iasi; 1995; 99(1-2):151-3. PubMed ID: 9524673 [TBL] [Abstract][Full Text] [Related]
15. The effect of methylprednisolone pulse treatment on cytokine network in Graves ophthalmopathy. Lacka K; Manuszewska E; Korczowska I; Lacki JK Curr Eye Res; 2007 Mar; 32(3):291-7. PubMed ID: 17453949 [TBL] [Abstract][Full Text] [Related]
16. Methylprednisolone pulse therapy for patients with moderately severe Graves' orbitopathy: a prospective, randomized, placebo-controlled study. van Geest RJ; Sasim IV; Koppeschaar HP; Kalmann R; Stravers SN; Bijlsma WR; Mourits MP Eur J Endocrinol; 2008 Feb; 158(2):229-37. PubMed ID: 18230831 [TBL] [Abstract][Full Text] [Related]
18. Methylprednisolone and hepatotoxicity in Graves' ophthalmopathy. Wichary H; Gasińska T Thyroid; 2012 Jan; 22(1):64-9. PubMed ID: 22029719 [TBL] [Abstract][Full Text] [Related]
19. [The influence of treatment of progressive edematous infiltrative ophthalmopathy on intraocular pressure]. Rutecka-Debniak A; Krzystolik Z; Pilarska K; Krzyzanowska-Swiniarska B; Syrenicz A; Jarema A Klin Oczna; 1999; 101(3):195-200. PubMed ID: 10526444 [TBL] [Abstract][Full Text] [Related]
20. [Combined therapy with cyclosporin A and cortisone in endocrine Basedow endocrine orbitopathy: successful use in compressive optic neuropathy]. Weissel M; Zielinski CC; Hauff W; Till P Acta Med Austriaca; 1993; 20(1-2):9-13. PubMed ID: 8475683 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]